These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 714306)

  • 1. [Renal perfusion and the renin-angiotensin system in hepatic cirrhosis].
    Bosch Y; Arroyo V; Mauri M; Rivera F; Rodes J
    Minerva Med; 1978 Oct; 69(47):3249-55. PubMed ID: 714306
    [No Abstract]   [Full Text] [Related]  

  • 2. Renal failure in advanced liver disease.
    Baldus WP
    Prog Liver Dis; 1972; 4():251-67. PubMed ID: 4347066
    [No Abstract]   [Full Text] [Related]  

  • 3. [Influence of Na supplement and limitation on blood PRA, AII, ALD and renal function in patients with liver cirrhosis].
    Gu XB; Chen HK; Zhu YF; Pei H; Liu XY
    Zhonghua Gan Zang Bing Za Zhi; 2004 Jun; 12(6):370. PubMed ID: 15225438
    [No Abstract]   [Full Text] [Related]  

  • 4. Hepatic hemodynamics and the renin-angiotensin-aldosterone system in cirrhosis.
    Bosch J; Arroyo V; Betriu A; Mas A; Carrilho F; Rivera F; Navarro-Lopez F; Rodes J
    Gastroenterology; 1980 Jan; 78(1):92-9. PubMed ID: 7350041
    [No Abstract]   [Full Text] [Related]  

  • 5. [Acute kidney failure and the renin-angiotensin-aldosterone system].
    Bystrovskiĭ VF
    Klin Med (Mosk); 1985 Apr; 63(4):13-6. PubMed ID: 3897697
    [No Abstract]   [Full Text] [Related]  

  • 6. Plasma angiotensin II, renin, renin-substrate and aldosterone concentrations in acute renal failure in man.
    Paton AM; Lever AF; Oliver NW; Medina A; Briggs JD; Morton JJ; Brown JJ; Robertson JI; Fraser R; Tree M; Gavras H
    Clin Nephrol; 1975 Jan; 3(1):18-23. PubMed ID: 1126059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The influence of saralasine on blood pressure and renal function in Bartter's syndrome and decompensated hepatic cirrhosis (author's transl)].
    Klaus D; Witzgall H; Zehner J; Dürr H; Lange H
    Dtsch Med Wochenschr; 1976 Sep; 101(37):1357-9. PubMed ID: 954592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The renin-angiotensin-aldosterone system in parenchymatous liver diseases].
    Wernze H
    Internist (Berl); 1976 Mar; 17(3):136-41. PubMed ID: 177382
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of single dose of 50mg captopril in patients with liver cirrhosis and ascites.
    Lee JK; Hsieh JF; Tsai SC; Ho YJ; Kao CH
    Hepatogastroenterology; 2000; 47(33):767-70. PubMed ID: 10919029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Mutual interaction of the renin-angiotensin system and the atrial natriuretic factor in the renal response to acute volume loading].
    Horký K; Tesar V; Gregorová I; Srámková J; Dvoráková J
    Vnitr Lek; 1990 Jul; 36(7):625-32. PubMed ID: 2147304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Kideny and hepato-biliary diseases].
    Thiele KG
    Dtsch Med Wochenschr; 1976 Jul; 101(30):1134-40. PubMed ID: 942568
    [No Abstract]   [Full Text] [Related]  

  • 12. Renal hemodynamics and the renin-angiotensin system in cirrhosis.
    Aliaga L; Zozaya JM; Quiroga J; Richter JA; Prieto J
    Rev Esp Fisiol; 1989; 45 Suppl():371-5. PubMed ID: 2701770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Significance of renin in physiopathology and diagnosis].
    Kokot F
    Z Gesamte Inn Med; 1969 Apr; 24(7):193-7. PubMed ID: 4308357
    [No Abstract]   [Full Text] [Related]  

  • 14. Some aspects of kidney function, the renin-aldosterone system and sympathetic activity in essential hypertension.
    Pedersen EB
    Acta Med Scand Suppl; 1980; 636():1-66. PubMed ID: 6103641
    [No Abstract]   [Full Text] [Related]  

  • 15. The effects of aldosterone and angiotensin on renal function.
    Louis WJ; Doyle AE
    Clin Sci; 1966 Apr; 30(2):179-89. PubMed ID: 4287511
    [No Abstract]   [Full Text] [Related]  

  • 16. Renin, aldosterone and renal haemodynamics in cirrhosis with ascites.
    Arroyo V; Bosch J; Mauri M; Viver J; Mas A; Rivera F; Rodes J
    Eur J Clin Invest; 1979 Feb; 9(1):69-73. PubMed ID: 110603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiovascular and renal effects of low-dose atrial natriuretic peptide in compensated cirrhosis.
    La Villa G; Lazzeri C; Pascale A; Sestini S; Bisi G; Sciagrà R; Vecchiarino S; Raggi VC; Barletta G; Laffi G; Gentilini P
    Am J Gastroenterol; 1997 May; 92(5):852-7. PubMed ID: 9149200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Renal insufficiency in decompensated liver cirrhosis. Report of 5 cases and a review of the pathophysiology].
    Thomsen AC
    Ugeskr Laeger; 1968 Apr; 130(14):585-91. PubMed ID: 4303382
    [No Abstract]   [Full Text] [Related]  

  • 19. Inappropriately low angiotensin II generation: a factor determining reduced kidney function and survival in patients with decompensated cirrhosis.
    Sansoé G; Silvano S; Mengozzi G; Todros L; Smedile A; Touscoz G; Rosina F; Rizzetto M
    J Hepatol; 2004 Mar; 40(3):417-23. PubMed ID: 15123355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes of blood pressure, plasma renin activity and plasma aldosterone concentration following the infusion of Sar1-Ile8-angiotensin II in hypertensive, fluid and electrolyte disorders.
    Yamamoto T; Doi K; Ogihara T; Ichihara K; Hata T; Kumahara Y
    Prog Biochem Pharmacol; 1976; 12():174-89. PubMed ID: 1019163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.